From left, Haltec Vice President Dave Caruso, National Account Manager Michael Adelman and President Tom Moyer show off the trophy presented to the company as the SBA’s 2024 Great Lakes Regional ...

MINNEAPOLIS--(BUSINESS WIRE)--Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. (NYSE: MDT), today announced the start of the first of several new ...

Mechanism and suitability The CoreValve is a bioprosthetic porcine pericardial valve mounted in a nitinol stent, which is compressed into an 18F delivery catheter. When deployed, it self-expands when ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced that the FDA has approved its self-expanding transcatheter CoreValve System for patients ...

MINNEAPOLIS - Medtronic, Inc. today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic ...

The CoreValve transcatheter valve gained accelerated approval on June 12, 2014, from the US Food and Drug Administration for treatment of patients with severe aortic stenosis who are at high risk for ...

Medtronic CoreValve System The FDA has approved the CoreValve System, a self-expanding transcatheter for patients with severe aortic stenosis who are too ill or frail to have their aortic valves ...